UK Bioindustry Association and the Royal College of Physicians announce new collaboration
The BioIndustry Association and the Royal College of Physicians of London (RCP) have announced a collaborative partnership, offering both memberships increased opportunities to engage on issues such as innovation, access to the NHS and regulation.
As part of our collaboration, RCP is offering healthcare professionals who are BIA members a personal discount to their Annual Conference and flagship event celebrating their 500th anniversary year. The conference, Innovation in Medicine 2018, covers all 31 medical specialties, including clinical genetics, and a track focussing on the future of medicine. Corporate members are also invited to book a pod in the industry zone at the conference at discounted rates.
In return, the BIA is offering RCP members and fellows special RCP-only rates to their BIA/MHRA Joint Conference and the UK BioScience Forum.
BIA CEO, Steve Bates, said: “We look forward to working with the RCP to see how both memberships can draw on each other’s expertise to boost the UK’s capabilities in research and development to bring innovative new treatments to patients.”
Royal College of Physicians Academic Vice President, Professor Margaret Johnson, said: “The collaboration offers a great opportunity to share knowledge and we would encourage BIA members to attend Innovation in Medicine 2018 as delegates, or support the event and present in the industry zone where they can tell their story to more than 1000 consultants and physicians.”
More detail on the Innovation in Medicine 2018 conference can be found here.
Notes to editors
- Ed Sexton, Communications and Media Relations Manager, BIA firstname.lastname@example.org 0207 630 2196
- Linda Cuthbertson | Head of PR and public affairs 020 3075 1254 email@example.com
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.